CD8A and neoplasm: These newly appearing B cells participated in the formation of TLS and significantly increased the number and cytotoxicity of tumor-specific CD8+ T cells (104).Another topoisomerase II inhibitor, teniposide, can induce ICD, but its mechanism of action is different from that of anthracyclines.